Thromboresistance of Polyurethane Plates Modified with Quaternized Chitosan and Heparin
- 2 June 2022
- journal article
- research article
- Published by Pleiades Publishing Ltd in Applied Biochemistry and Microbiology
- Vol. 58 (3) , 315-321
Abstract
To obtain modified polyurethane (PU) plates, quaternized chitosan (QuatCh; degree of substitution 50%, degree of deacetylation 87%) and unfractionated heparin (UFH) were applied in layers to the plate surfaces. The relief of the surface of the plates was studied via atomic-force microscopy (AFM). After processing, the root-mean-square roughness and the height of the unevenness of the PU profile of the plates significantly increased. The value of the contact angle of the modified PU plates decreased from 86.1° ± 11.3° to 63.2° ± 3.68°. Donor blood and the blood recalcification time test were used to assess the in vitro resistance of the PU plates to the appearance of blood clots on the surface (thromboresistance, TR). When the modified PU plates were incubated with blood for 20–180 min, the TR reached 78.43 ± 4.02–88.94 ± 1.98%. The recalcification time of human blood containing PU plates coated with QuatCh–UFH (483 ± 22.64 s for 20 min of incubation and576.5 ± 24.64 s for 40 min of incubation) significantly differed from the recalcification time of human blood containing PU plates without coating (257.5 ± 12.84 s for 20 min of incubation and 273.3 ± 16.6 s for 40 min of incubation). Thus, layer-by-layer modification of the PU plates with QuatCh and UFH led to a high resistance to the appearance of blood clots on the surface.Keywords
This publication has 23 references indexed in Scilit:
- Investigation of the properties of N-[(2-hydroxy-3-trimethylammonium) propyl] chloride chitosan derivativesInternational Journal of Biological Macromolecules, 2019
- Design, synthesis, and biomedical applications of synthetic sulphated polysaccharidesChemical Society Reviews, 2019
- Polydopamine Modified TiO2 Nanotube Arrays for Long-Term Controlled Elution of Bivalirudin and Improved HemocompatibilityACS Applied Materials & Interfaces, 2017
- Heparin coatings for improving blood compatibility of medical devicesAdvanced Drug Delivery Reviews, 2017
- Device thrombosis and pre-clinical blood flow models for assessing antithrombogenic efficacy of drug-device combinationsAdvanced Drug Delivery Reviews, 2017
- Improvement in physical and biological properties of chitosan/soy protein films by surface grafted heparinInternational Journal of Biological Macromolecules, 2016
- Corn trypsin inhibitor coating attenuates the prothrombotic properties of catheters in vitro and in vivoActa Biomaterialia, 2012
- The influence of size and charge of chitosan/polyglutamic acid hollow spheres on cellular internalization, viability and blood compatibilityBiomaterials, 2010
- Conformational transitions induced in heparin octasaccharides by binding with antithrombin IIIBiochemical Journal, 2006
- Blood Recalcification Time: A Simple and Reliable Test to Monitor Heparin TherapyAmerican Journal of Clinical Pathology, 1976